Medtronic plc is an American-Irish medical device company. The company's legal and executive headquarters are in Ireland, while its operational headquarters are in Minneapolis, Minnesota. Medtronic rebased to Ireland following its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United St…
An institutional-grade, numbers-driven thesis on MDT — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of August 8, 2026, TradersQuant's model rates Medtronic PLC (MDT) 64/100 with a 12-month base-case forecast of $89.18 — +2.3% versus the current price of $87.16. Medtronic PLC trades at $87.16 in the Health Care sector, with a market capitalisation of $111.57B. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month TradersQuant model price target for MDT is $89.18, implying +2.3% versus the current price. The model's 12-month scenario range runs from $83.73 (bear) to $102.09 (bull), with a base case of $89.18.
On the fundamentals, Medtronic shows a P/E of 22.8, trailing revenue of $36.14B, revenue growth of +8.4% YoY, a dividend yield of 3.35%. This page also tracks MDT's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
MDT currently carries a TradersQuant composite score of 64/100, which we read as a neutral-to-watch signal. The Wall-Street analyst consensus is "buy". Our 12-month price target of $89.18 implies +2.3% from $87.16. This is research, not financial advice — always combine it with your own judgement.
The TradersQuant 12-month model price target for MDT is $89.18, about +2.3% versus the latest price of $87.16. Consensus is based on 34 analysts.
TradersQuant's 12-month model forecast for MDT is a base case of $89.18, ranging from $83.73 (bear) to $102.09 (bull), an expected return of +2.3%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for MDT over the next 12 months is $89.18 in the base case (bear $83.73, bull $102.09), versus today's price of $87.16. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for MDT — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates MDT's fair value at $115.23, implying +32.2% of expected upside versus the current price.
Yes — Medtronic pays a dividend yielding 3.35% (about $2.92 per share annually).
Data and model outputs are for research only and are not financial advice. Figures update continuously.
